Medicines Evaluation Unit Limited
03779957
Healthy
- Going concern doubt noted in accounts (-10)
Details
Compliance
Last accounts
31/03/2025
medium
Next accounts due
30/09/2026
Confirmation statement
Last: 28/05/2025
Due 11/06/2026
Industry
Officers
director · Since 13/06/2025
VP, HEAD OF EARLY CLINICAL DEVELOPMENT
BRITISH · UNITED KINGDOM · Age 56
Also on 2 other boards
director · Since 13/06/2025
SVP, GLOBAL SITE MANAGEMENT
BRITISH · UNITED KINGDOM · Age 45
Also on 4 other boards
director · Since 13/06/2025
ACCOUNTANT
BRITISH · UNITED KINGDOM · Age 57
Also on 26 other boards
Persons with Significant Control
Iqvia Ltd.
3 Forbury Place, 23 Forbury Road, Reading, RG1 3JH
Reg: 03022416 · Companies House · Private Limited Company
Notified 13/06/2025
Former PSCs
North West Lung Research Centre Charity
Ceased 13/06/2025
Charges0 outstanding
CLYDESDALE BANK PLC (TRADING AS BOTH CLYDESDALE AND YORKSHIRE BANK) (COMPANY NUMBER SC001111)
NORTH WEST LUNG CENTRE
CompanyRankvs 180+ SIC 72190 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 31/03/2025
Turnover
£18.2M
Annual revenue
Net Worth
£38.3M
Balance sheet strength
Cash
£33.2M
Cash in the bank
Profit Before Tax
£6.0M
Bottom line earnings
Net Current Assets
£35.2M
Working capital
Current Assets
£37.8M
Current Liabilities
£2.6M
Fixed Assets
£3.1M
Debtors
£4.6M
Cost of Sales
£8.0M
Gross Profit
£10.2M
Admin Expenses
£4.6M
Operating Profit
£5.6M
Profit After Tax
£5.3M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 14.63 | +£0 |
| 2025 | 14.63 | +£3.7M |
| 2024 | 11.13 | +£4.4M |
| 2023 | 6.30 | +£3.9M |
| 2022 | 6.19 | +£4.2M |
| 2021 | 9.78 | +£3.6M |
| 2020 | 12.60 | — |
Derived from filed accounts. Not audited figures.